Search Results - "Zustovich, F."

Compliance to diagnostic and therapeutic pathways and innovative drug recommendations in advanced non-small cell lung cancer: preliminary results from the MOST study by Pasello, G., Vicario, G., Gori, S., Zustovich, F., Bonetti, A., Rosetti, F., Favaretto, A., Oniga, F., Bria, E., Toso, S., Boccalon, M., Oliani, C., Palazzolo, G., Frega, S., Basso, M., Pertile, P., Bortolami, A., Verrienti, R., Scanni, R., Conte, P.

Get full text

P17.53 THE COMBINATION OF CARMUSTINE WAFERS AND FOTEMUSTINE IN RECURRENT GLIOBLASTOMA PATIENTS: OUR EXPERIENCE by Lombardi, G., Puppa, A. D., Zustovich, F., Pambuku, A., Farina, P., Zagonel, V.

“…BACKGROUND: In the last years, few advances have been made improving progression-free survival and overall survival in patients with glioblastoma multiforme…”
Get full text

Metastatic oligodendrogliomas: a review of the literature and case report by Zustovich, F., Della Puppa, A., Scienza, R., Anselmi, P., Furlan, C., Cartei, G.

“…Summary Oligodendroglioma cells are detectable in the cerebro-spinal fluid in up to 14% of patients [10] and cerebellar and/or spinal cord involvement is a…”
Get full text

8746 POSTER Could Hypertension Be a Potential Biomarker in Patients With Recurrent Glioblastoma Treated With Antiangiogenic Drugs? -a Retrospective Analysis by Lombard!, G, Zustovich, F, Fiduccia, P, Farina, P, Puppa, A. Delia, Orvieto, E, Gardiman, M.R, Berti, F, Zagonel, V

Get full text

Erysipeloid skin toxicity induced by gemcitabine by Zustovich, F, Pavei, P, Cartei, G

Get full text

Paraneoplastic diffuse cutaneous papillomatosis by Zustovich, F, Lombardi, G, Cartei, G

Get full text

Gemcitabine and liposomal doxorubicin in biliary and hepatic carcinoma (HCC) chemotherapy: preliminary results and review of the literature by Pastorelli, D., Cartei, G., Zustovich, F., Marchese, F., Artioli, G., Zovato, S., Binato, S., Ceravolo, R., Cingarlini, S., Salmaso, F., Mattiazzi, M., Sanavio, C., Farinati, F., Zanus, G., Cillo, U.

“…Advanced biliary tract cancers have a poor prognosis. Gemcitabine (G) as a single agent or in combination represents an active treatment option. Systemic…”
Get full text

P49 Chemotherapy in older women with ovarian cancer by Furini, L, Artioli, G, Lombardi, G, Zustovich, F, Faggioni, G, Scattolin, G, Carli, P, Pastorelli, D, Nicoletto, M.O

Get full text

Chronic Anemia Due to Mitomycin C Is Drug Dose-Dependent, Normocytic, Progressive, Related to Erythropoietin Levels and Quantitatively Predictable: Implications for Radiochemotherapy by Cartel, G., Colombrino, E., Sanzari, M.C., Plebani, M., Micucci, M., Fiorica, F., Glraldi, T., Zustovich, F., Cartel, F.

“…C.Mitomycin C (Me) is used as therapy against solid tu- mors, also combined with other chemotherapeutic agents or radiotherapy. It may cause acute, subacute,…”
Get full text

Haemorrhagic presentation of low-grade glioma in adults by Della Puppa, A, Zustovich, F, Gardiman, M, Manara, R, Cecchin, D, Scienza, R

“…Intracranial bleeding is rare in patients with low-grade gliomas, above all in adult population. We reviewed the literature of such cases and reported another…”
Get full text

Internal auditory canal metastasis by Della Puppa, A, Rossetto, M, Berti, F, Zustovich, F, Manara, R, Gardiman, M P, Scienza, R

“…Metastasis of the inner auditory canal is a really rare event. Clinically, it usually presents with rapid worsening cranial nerve palsy. Authors present a…”
Get more information

Characteristics and management of pancreatic lesions in Von Hippel-Lindau disease: a systematic literature review by Giuseppe Lombardi, F. Zustovich, S. Zovato, D. Fiore, A. Cappetta, D. Pastorelli

“…Von Hippel-Lindau disease is a rare autosomal dominant inherited disorder that predisposes the occurrence of cysts and various types of cancers such as…”
Get full text

A phase II study of Gemcitabine and immunotherapy in renal cancer: preliminary results and review of the literature by Zustovich, F., Cartei, G., Dal Bianco, M., De Zorzi, L., Ceravolo, R., Zovato, S., Salmaso, F., Binato, S., Artioli, G., Cingarlini, S., Pastorelli, D.

Get full text

8715 Cisplatin and Temozolomide in heavily pretreated and poor performance status (PS) patients with temozolomide refractory glioblastoma by Lombardi, G, Zustovich, F, Carli, P, Puppa, A. Della, Rotilio, A, Scienza, R, Pastorelli, D

Get full text

6620 Pegylated liposomal doxorubicin (PLD) and gemcitabine (G) in the treatment of advanced hepatocellular carcinoma (HCC) by Pastorelli, D, Zustovich, F, Lombardi, G, Zovato, S, Farina, M, Furini, L, Faggioni, G, Nicoletto, M.O, Ceravolo, R

Get full text

417P New insights into second-line (2L) choices after CDK4/6 inhibitors (CDK4/6i) in hormone receptor-positive (HR+)/ human epidermal growth factor 2-negative (HER2-) metastatic breast cancer (MBC) patients (pts): Preliminary results of the HERMIONE-13 study by Cogliati, V., Rossi, E., Turla, A., Ambroggi, M., Berardi, R., Borella, F., Coltelli, L., De Giorgi, U.F.F., Ferro, A., Garrone, O., Giordano, M., Landucci, E., Mazzotta, M., Moretti, G., Palumbo, R., Vici, P., Zustovich, F., Riva, F., Capici, S., Cazzaniga, M.E.

Get full text

2125P Potential ROle of hypoVItaminosis D in patiENts with cancer treated with immune ChEckpoint inhibitors (PROVIDENCE): A prospective observational study by Cortellini, A., Leonetti, A., Parisi, A., Tiseo, M., Bordi, P., Michiara, M., bui, S., Cosenza, A., Ferri, L., Giudice, G.C., Testi, I., Vincenzi, B., Santo, V., Ricozzi, V., Sgargi, P., Zustovich, F., Stucci, L.S., Santini, D., Buti, S., Bersanelli, M.

Get full text

1666P Non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) guideline application in real-world: Multi-Institutional based survey of adjuvant and first-line pancreatic ductal adenocarcinoma treatment in Italy (GARIBALDI) by Pinto, C., Milella, M., Bergamo, F., Di Marco, M.C., Cardellino, G.G., Cavanna, L., Giommoni, E., Zustovich, F., Bonomi, M., Bozzarelli, S., Vicario, G., Parlagreco, E., Frassineti, G.L., Macchini, M., Orsi, G., Santoni, A., Caldirola, L., De Simone, I., Reni, M.

Get full text

Therapeutic opportunities for castration-resistant prostate cancer patients with bone metastases by Zustovich, Fable, Fabiani, Francesca

“…Abstract Patients with castration-resistant prostate cancer are burdened not only with an unavoidable risk of mortality but also by severe mobility issues…”
Get full text

A validated prognostic classifier for BRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’ study by Loupakis, Fotios, Intini, Rossana, Cremolini, Chiara, Orlandi, Armando, Sartore-Bianchi, Andrea, Pietrantonio, Filippo, Pella, Nicoletta, Spallanzani, Andrea, Dell’Aquila, Emanuela, Scartozzi, Mario, De Luca, Emmanuele, Rimassa, Lorenza, Formica, Vincenzo, Leone, Francesco, Calvetti, Lorenzo, Aprile, Giuseppe, Antonuzzo, Lorenzo, Urbano, Federica, Prenen, Hans, Negri, Francesca, Di Donato, Samantha, Buonandi, Pasquale, Tomasello, Gianluca, Avallone, Antonio, Zustovich, Fable, Moretto, Roberto, Antoniotti, Carlotta, Salvatore, Lisa, Calegari, Maria Alessandra, Siena, Salvatore, Morano, Federica, Ongaro, Elena, Cascinu, Stefano, Santini, Daniele, Ziranu, Pina, Schirripa, Marta, Buggin, Federica, Prete, Alessandra Anna, Depetris, Ilaria, Biason, Paola, Lonardi, Sara, Zagonel, Vittorina, Fassan, Matteo, Di Maio, Massimo

Get full text